The Self-Driving Lab

AI-driven robotics for challenging biologics formulation. We replace slow, manual formulation workflows with a closed-loop platform that cuts development timelines and material usage; bringing antibody therapies home, faster.


Learn More:

Matthew Tamasi, PhD | Co-Founder & CEO

matthew.tamasi@plexymer.com

New Site Under Construction